The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01251289
First received: November 30, 2010
Last updated: June 8, 2012
Last verified: December 2009
  Purpose

A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center


Condition
Group B Streptococcus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center

Further study details as provided by St. Michael's Hospital, Toronto:

Enrollment: 628
Study Start Date: December 2009
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Detailed Description:

This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Group B streptococcus positive pregnant women

Criteria

Inclusion Criteria:

  • GBS positive pregnant women

Exclusion Criteria:

  • n/a
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01251289

Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto
  More Information

No publications provided

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01251289     History of Changes
Other Study ID Numbers: REB 09-072
Study First Received: November 30, 2010
Last Updated: June 8, 2012
Health Authority: St. Michael's Hospital:

ClinicalTrials.gov processed this record on April 14, 2014